Cargando…

Effect of Phoxilium on prognostic predictors in patients undergoing continuous venovenous hemodiafiltration

BACKGROUND: Phosphorus-containing dialysis solution is used to prevent hypophosphatemia in patients undergoing continuous venovenous hemodiafiltration (CVVHDF). This study evaluated the effect of phosphorus-containing dialysis solution on mortality in patients undergoing CVVHDF based on changes in p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Da Woon, Kim, Hyo Jin, Kim, Jin Mi, Jeon, You Hyun, Han, Miyeun, Seong, Eun Young, Song, Sang Heon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Nephrology 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476306/ https://www.ncbi.nlm.nih.gov/pubmed/34370933 http://dx.doi.org/10.23876/j.krcp.20.217

Ejemplares similares

Pharmacokinetics of daptomycin in patients undergoing low-flow continuous venovenous hemodiafiltration
por: Ide, TI, et al.
Publicado: (2015)

Near-infrared spectroscopy parameters in patients undergoing continuous venovenous hemodiafiltration
por: Chaves, Renato Carneiro de Freitas, et al.
Publicado: (2019)

Regional Anticoagulation with Citrate is Superior to Systemic Anticoagulation with Heparin in Critically Ill Patients Undergoing Continuous Venovenous Hemodiafiltration
por: Park, Joon-Sung, et al.
Publicado: (2011)

Pharmacokinetics and pharmacodynamics of esomeprazole and ranitidine during continuous venovenous hemodiafiltration
por: Fuhrmann, V, et al.
Publicado: (2013)

Cefiderocol Pharmacokinetics in a Patient Receiving Continuous Venovenous Hemodiafiltration
por: Kobic, Emir, et al.
Publicado: (2021)

Hypercitratemia is a mortality predictor among patients on continuous venovenous hemodiafiltration and regional citrate anticoagulation
por: dos Santos, Thais Oliveira Claizoni, et al.
Publicado: (2023)

Variability in Uremic Control during Continuous Venovenous Hemodiafiltration in Trauma Patients
por: Beitland, Sigrid, et al.
Publicado: (2012)

Role of early continuous venovenous hemodiafiltration in septic shock and multiorgan failure
por: Soliman, M, et al.
Publicado: (2010)

Dynamics of the dosage of citrate-calciuminfusion regimens as anticoagulation in continuous venovenous hemodiafiltration
por: Marin Mateos, H, et al.
Publicado: (2015)

Characteristics of continuous venovenous hemodiafiltration in the acute treatment of inherited metabolic disorders
por: Eminoğlu, Fatma Tuba, et al.
Publicado: (2021)

Phoxilium(®) reduces hypophosphataemia and magnesium supplementation during continuous renal replacement therapy
por: Godaly, Gabriela, et al.
Publicado: (2016)

Carbon dioxide elimination during continuous venovenous hemodiafiltration (CVVHD)-laboratory experiment
por: Ruzicka, J, et al.
Publicado: (2000)

Regional citrate anticoagulation (RCA) for continuous venovenous hemodiafiltration (CVVHDF): initial experience
por: Durão, M, et al.
Publicado: (2001)

Optimal doses of caspofungin during continuous venovenous hemodiafiltration in critically ill patients
por: Aguilar, Gerardo, et al.
Publicado: (2017)

Flexitrate regional citrate anticoagulation in continuous venovenous hemodiafiltration: a retrospective analysis
por: Lenga, Ilan, et al.
Publicado: (2019)

Comparison of Sustained Hemodiafiltration with Acetate-Free Dialysate and Continuous Venovenous Hemodiafiltration for the Treatment of Critically Ill Patients with Acute Kidney Injury
por: Abe, Masanori, et al.
Publicado: (2011)

Atenolol and amlodipine combination overdose managed with continuous venovenous hemodiafiltration: A case report
por: Sandeep, P., et al.
Publicado: (2014)

Evaluation of optimized continuous venovenous hemodiafiltration therapy efficiency in severe burn patients with sepsis
por: Xu, Cheng, et al.
Publicado: (2014)

Acid base variables predict survival early in the course of treatment with continuous venovenous hemodiafiltration
por: Passos, Rogério da Hora, et al.
Publicado: (2018)

Optimizing ceftolozane-tazobactam dosage in critically ill patients during continuous venovenous hemodiafiltration
por: Aguilar, Gerardo, et al.
Publicado: (2019)

A Population Pharmacokinetic Model-Guided Evaluation of Ceftolozane-Tazobactam Dosing in Critically Ill Patients Undergoing Continuous Venovenous Hemodiafiltration
por: Sime, Fekade B., et al.
Publicado: (2019)

Amino acid concentrations in serum, urine and dialysate/ultrafiltrate solutions of continuous venovenous hemodiafiltration patients
por: Lee, JM, et al.
Publicado: (2012)

Impedance cardiography in the estimation of hemodynamic and fluid status of coma patients during continuous venovenous hemodiafiltration
por: De Nicola, A, et al.
Publicado: (2009)

Effectiveness of continuous venovenous hemodiafiltration using a polymethylmethacrylate membrane hemofilter in septic shock patients
por: Sakamoto, Y, et al.
Publicado: (2008)

Continuous venovenous hemodiafiltration in the treatment of newborns with an inborn metabolic disease: a single center experience
por: AKDUMAN, Hasan, et al.
Publicado: (2020)

Hemoadsorption and continuous venovenous hemodiafiltration in the management of paraquat poisoning during pregnancy: A case report
por: Ballesteros, David A., et al.
Publicado: (2023)

Factors affecting serum concentration of vancomycin in critically ill oliguric pediatric patients receiving continuous venovenous hemodiafiltration
por: Lee, Bongjin, et al.
Publicado: (2018)

The combination of lactate and bicarbonate buffers in continuous venovenous hemodiafiltration and its impact on serum lactate levels and homeostasis
por: Balik, M, et al.
Publicado: (2000)

Use of Hypertonic Continuous Venovenous Hemodiafiltration to Control Intracranial Hypertension in an End-Stage Renal Disease Patient
por: Rifkin, Stephen I., et al.
Publicado: (2010)

Pilot study on a regional citrate anticoagulated continuous venovenous hemodiafiltration protocol with variable treatment dose
por: Slowinski, T, et al.
Publicado: (2010)

Blood epuration of middle molecules in continuous venovenous hemodiafiltration with regional citrate anticoagulation versus systemic heparinization
por: Nogier, MB, et al.
Publicado: (2009)

High‐volume continuous venovenous hemodiafiltration plus resin hemoperfusion improves severe metformin‐associated toxicity
por: Liu, Shuangxin, et al.
Publicado: (2017)

Successful treatment of linezolid-induced severe lactic acidosis with continuous venovenous hemodiafiltration: A case report
por: Zhang, Naiju, et al.
Publicado: (2022)

Severe Rhabdomyolysis and Acute Renal Failure Treated by Continuous Venovenous Hemodiafiltration in a Child with Diabetic Ketoacidosis
por: Yaman, Ayhan
Publicado: (2022)

Monocytes, endoplasmic reticulum stress and metabolomics in dogs with multiple organ dysfunction syndrome treated by continuous venovenous hemodiafiltration
por: Xu, Yun-Peng, et al.
Publicado: (2017)

Severe COVID-19 in a patient with chronic kidney disease: Is there a positive effect of continuous venovenous hemodiafiltration?
por: Xing, Xue, et al.
Publicado: (2021)

Severe COVID-19 in a patient with chronic kidney disease: Is there a positive effect of continuous venovenous hemodiafiltration?
por: Xing, Xue, et al.
Publicado: (2021)

Use of Multifrequency Bioimpedance Analysis in Male Patients with Acute Kidney Injury Who Are Undergoing Continuous Veno-Venous Hemodiafiltration
por: Rhee, Harin, et al.
Publicado: (2015)

Hospital mortality and prognostic factors in critically ill patients with acute kidney injury and cancer undergoing continuous renal replacement therapy
por: Kim, Da Woon, et al.
Publicado: (2022)

Extracorporeal treatment with high-volume continuous venovenous hemodiafiltration and charcoal-based sorbent hemoperfusion for severe metformin-associated lactic acidosis
por: Garg, Suneel Kumar, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_9od41g5393ch1vrm1s0pip5nog